Piedmont Investment Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-4,411
Closed -$426K 546
2020
Q1
$426K Sell
4,411
-7
-0.2% -$676 0.02% 472
2019
Q4
$409K Sell
4,418
-564
-11% -$47.4K 0.01% 609
2019
Q3
$382K Buy
+4,982
New +$436K 0.01% 639
2019
Q2
Sell
-9,841
Closed -$581K 1192
2019
Q1
$581K Buy
9,841
+552
+6% +$31.7K 0.02% 457
2018
Q4
$490K Buy
9,289
+319
+4% +$18.7K 0.02% 468
2018
Q3
$497K Buy
8,970
+187
+2% +$9.64K 0.02% 521
2018
Q2
$413K Buy
8,783
+771
+10% +$31.7K 0.02% 510
2018
Q1
$290K Buy
8,012
+312
+4% +$11K 0.01% 583
2017
Q4
$279K Sell
7,700
-437
-5% -$15.8K 0.01% 589
2017
Q3
$312K Buy
8,137
+161
+2% +$6.75K 0.01% 561
2017
Q2
$331K Buy
+7,976
New +$303K 0.01% 532

Other funds holding RGEN

Piedmont Investment Advisors's RGEN Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Repligen (RGEN) in Q2 2020, closing a stake of 4,411 shares — an estimated $426K sold.

Piedmont Investment Advisors first reported a position in RGEN in Q2 2017 and held it in 11 quarters. The position peaked at $581K in Q1 2019. 370 funds tracked by Wall St. Rank hold RGEN as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Repligen position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 4,411 Repligen shares in Q2 2020, an estimated $426K.
  • Piedmont Investment Advisors first reported a position in Repligen in Q2 2017 and held it in 11 quarters.
  • Piedmont Investment Advisors's Repligen position peaked at $581K in Q1 2019.
  • 370 funds tracked by Wall St. Rank held Repligen as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.